If you have been diagnosed with a hematologic condition, such as sickle cell disease, autoimmune thrombocytopenia, aplastic anemia, or thalassemia you may want to discuss the chance that your hematologic treatment may affect your fertility with your hematologist.
Gonadotoxic agents, traditionally used to treat cancer, are increasingly used for the treatment of hematologic conditions. However, infertility and premature ovarian insuffiency are common following gonadotoxic treatment, such as hematopoietic stem cell transplantation (HCT).
Your hematologist can work with a fertility specialist, such as a reproductive endocrinologist, to coordinate your fertility preservation care. It is important for your hematologist and fertility specialist to have an open line of communication about your hematologic treatment and available fertility options, as many hemotologic conditions confer an elevated risk of thrombosis and predisposition to painful vaso-occlusive events.
Your hematologist should discuss treatment-related infertility and help you understand your risks. Here are 5 questions to get the conversation started:
1. How is my hematologic condition affecting my health right now?
2. How quickly do I need to start treatment?
3. Will my disease or its treatment affect my future fertility?
4. What fertility options are out there?
5. Can I have a child after my treatment?
Learn more about your fertility preservation options or find community/online support:
If you have a specific fertility-related question or would like a referal for a fertility preservation consultation, call the Oncofertility Consortium® FERTline at 312-503-FERT or 866-708-FERT to speak with a patient navigator and find a reproductive specialist near you.